JP2004182628A - Apoptosis inducer of cancer cell - Google Patents

Apoptosis inducer of cancer cell Download PDF

Info

Publication number
JP2004182628A
JP2004182628A JP2002349884A JP2002349884A JP2004182628A JP 2004182628 A JP2004182628 A JP 2004182628A JP 2002349884 A JP2002349884 A JP 2002349884A JP 2002349884 A JP2002349884 A JP 2002349884A JP 2004182628 A JP2004182628 A JP 2004182628A
Authority
JP
Japan
Prior art keywords
oligosaccharide
arabino
cancer cell
solution
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002349884A
Other languages
Japanese (ja)
Other versions
JP3899462B2 (en
Inventor
Takeshi Fukami
健 深見
Yoshiaki Kitamura
義明 北村
Shinjiyushi Kobori
真珠子 小堀
Kazuki Yamamoto
和貴 山本
Koji Yamaki
幸二 八巻
Noriyoshi Nakanishi
載慶 中西
Atsushi Hiramatsu
淳 平松
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
San Ei Sucrochemical Co Ltd
National Food Research Institute
Original Assignee
San Ei Sucrochemical Co Ltd
National Food Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by San Ei Sucrochemical Co Ltd, National Food Research Institute filed Critical San Ei Sucrochemical Co Ltd
Priority to JP2002349884A priority Critical patent/JP3899462B2/en
Publication of JP2004182628A publication Critical patent/JP2004182628A/en
Application granted granted Critical
Publication of JP3899462B2 publication Critical patent/JP3899462B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Abstract

<P>PROBLEM TO BE SOLVED: To obtain a cancer cell apoptosis inducer which has ready purification operation and a high yield and is inexpensively and efficiently produced. <P>SOLUTION: The cancer cell apoptosis inducer comprises an arabinooligosaccharide-containing substance as a component which is obtained by hydrolyzing an arabinan-containing fiber component using an arabinooligosaccharide-forming enzyme by Penicillium sp. GALA22 deposited as FERM P-18941 and has ≤5 average polymerization degree. <P>COPYRIGHT: (C)2004,JPO&NCIPI

Description

【0001】
【発明が属する技術分野】
【0002】
本発明は、ガン細胞アポトーシス誘導剤に関し、詳細には、オリゴ糖含有物を成分とする、ガン細胞アポトーシス誘導剤に関する。
【0003】
【従来の技術】
【0004】
従来、オリゴ糖含有物を成分とするガン細胞アポトーシス誘導剤として、特許文献1である特開2001−86999号公報に記載されているように、海藻の細胞壁により得られたβ−1,3キシランをβ−1,3キシラナーゼで処理する事によりよって得られたβ−1,3キシロオリゴ糖を主成分とするものが知られている。
該ガン細胞アポトーシス誘導剤は、イヅワタ科の藻類であるスリコギヅタ等から、脱イオン水、1%塩酸溶液及び23%水酸化ナトリウム溶液での洗浄、亜塩素酸ナトリウム溶液による脱色、10%水酸化ナトリウム溶液による抽出、エタノール沈殿による分別精製処理を行うことで、原料として用いるβ−1,3キシランを得るものであった。
【0005】
【特許文献1】
特開2001−86999号公報
【0006】
【発明が解決しようとする課題】
【0007】
しかしながら、前記β−1,3キシロオリゴ糖を主成分とするガン細胞誘導アポトーシス誘導剤は、原料として用いるβ−1,3キシランを得るために、イヅワタ科の藻類であるスリコギヅタ等から、脱イオン水、1%塩酸溶液及び23%水酸化ナトリウム溶液での洗浄、亜塩素酸ナトリウム溶液による脱色、10%水酸化ナトリウム溶液による抽出、エタノール沈殿による分別精製処理、と多段階の処理を行う必要があるため、精製操作が非常に煩雑であり、かつ収量が低いという問題があり、安価で効率的に製造する事は非常に困難であった。
【0008】
従って、本発明が解決しようとする課題は、精製操作が容易であって、かつ収量が高く、安価で効率的に製造することが可能な、オリゴ糖含有物を成分とする、ガン細胞アポトーシス誘導剤を得ることにある。
【0009】
【課題を解決するための手段】
【0010】
本発明の課題を解決するための手段は、次のとおりである。
第1に、アラビノオリゴ糖含有物を成分とする、ガン細胞アポトーシス誘導剤。
第2に、平均重合度が10以下のアラビノオリゴ糖含有物を成分とする、ガン細胞アポトーシス誘導剤。
第3に、FERMP−18941として独立行政法人産業技術総合研究所特許生物寄託センターに寄託されているペニシリウム・エスピー(Penicillium sp.)GALA22によるアラビノオリゴ糖生成酵素を用い、アラビナン含有繊維分を加水分解することで得られたアラビノオリゴ糖含有物を成分とする、ガン細胞アポトーシス誘導剤。
ここで、アラビナン含有繊維分としては、ビート搾汁粕、ビートファイバー、ビートパルプ、リンゴ搾汁粕、リンゴファイバーの他にも、落花生粕、柑橘類の果皮又は果肉、オカラ、ダイズファイバーのいずれか一つ以上のものを使用できる。
第4に、前記アラビナン含有繊維分として、ビート搾汁粕を用いる、上記第3に記載のガン細胞アポトーシス誘導剤。
【0011】
本発明で使用するアラビノオリゴ糖組成物は、糖の平均重合度が10以下であることが好ましく、結合様式は特に限定されない。
平均重合度は、全糖量(アラビノース換算)/還元糖量(アラビノース換算)で定義した値であり、全糖量はフェノール・硫酸法で還元糖量はネルソン・ソモギ法で測定することで求められる。
【0012】
本発明におけるアラビノオリゴ糖とは、アラビノースが1〜10分子含まれる2〜10糖からなるオリゴ糖である。その結合様式は、α−1,5結合からなる直鎖状のものに限らず、α−1,2及びα−1,3結合を初めとする各種の分岐構造を有するものも含まれる。これには、キシロース、グルコース、ガラクトース、マンノース及びガラクツロン酸のようなアラビノース以外の糖の少なくとも一つが、還元末端や非還元末端、もしくは分子内に結合しているものも含まれる。
【0013】
また、本発明で使用するアラビノオリゴ糖含有物としては、粉末、液状、結晶あるいは顆粒の何れであっても良い。
【0014】
【発明の実施の形態】
【0015】
本発明で使用するアラビノオリゴ糖含有物は、ビート搾汁粕やリンゴ搾汁粕などに、エンドアラビナナーゼやアラビノフラノシダーゼ等の酵素を用いて加水分解処理してオリゴ糖混合物を得、このオリゴ糖混合物からアラビノオリゴ糖を分離回収することにより得ることができる。
その際に用いる酵素剤は、何れのものでも使用できる。
市販酵素を使用する場合には、精製品を入手するのは困難であることから、繊維分解酵素を使用しても良い。
その例としては、アマノエンザイム社製のペクチナーゼGアマノ(商品名)、新日本化学工業社製のスミチームAC(商品名)等が挙げられる。
【0016】
酵素によるビート搾汁粕やリンゴ搾汁粕などの加水分解処理は、遊離の酵素を使用しても担体に固定化した酵素を使用しても良い。
また、酵素による加水分解処理は、連続法で行っても、バッチ法で行っても良いし、酵素の種類や起源、酵素の添加量、処理時の温度、pH、温度等の諸条件を各状況に応じて選んで処理を行うと良い。
【0017】
上記のようにして得られたオリゴ糖を含有する糖混合物溶液は、常法によって分離される。
即ち、かかる場合に当該分野において通常使用されている周知の手段、例えば濾過、遠心分離、イオン交換または吸着クロマトグラフィー、膜濃縮、膜分離、溶媒抽出、減圧濃縮、結晶化等の操作が必要に応じて適宜組み合わせて用いられる。
一例を挙げれば、糖混合物溶液から濾過、遠心分離等によって繊維分等の残渣を除去し、次いでこの溶液を活性炭で処理して着色物質などを除き、更にイオン交換樹脂により脱塩した後、濃縮してシロップあるいは粉末状にすることができる。
【0018】
また、FERMP−18941として独立行政法人産業技術総合研究所特許生物寄託センターに寄託されているペニシリウム・エスピー(Penicillium sp.)GALA22によるアラビノオリゴ糖生成酵素を用い、アラビナン含有繊維分を加水分解することで得られる、アラビノオリゴ糖含有物の製造方法について、次に説明する。
【0019】
まず、ペニシリウム・エスピーGALA22を培養し、アラビノオリゴ糖生成酵素を調製する。
該菌株の培養は、炭素源、窒素源、無機塩類等を含む液体培地あるいは固形培地を用いて好気的条件下で実施する。
炭素源としては、ビート搾汁粕やリンゴ搾汁粕などのアラビナン含有繊維分などが使用される。
これら繊維分は、粉砕処理などを実施したものを用いることもできる。
窒素源としては、微生物により利用可能な窒素化合物、例えば酵母エキス、ペプトン、麦芽エキス、コーンスティープリカー等が使用される。
無機塩類としては、例えば硫酸マグネシウム、硝酸ナトリウム、リン酸二水素カリウム、水酸化カルシウム等の塩類が使用される。
尚、これらの炭素源、窒素源、無機塩類の他に、更に必要に応じて、糸状菌の生育に必要な各種の有機物、無機物を添加することができる。
上記の培地での培養方法は、固体培養あるいは液体培養の何れを用いても良いが、振盪培養あるいは発酵糟等を用いた通気攪拌培養が望ましい。
培養温度は、生育できる範囲内なら特に限定されないが、30℃付近が望ましい。
培養pHは、生育できる範囲内なら特に限定されないが、pH3〜5付近が望ましい。
培養時間は、特に限定されないが、24〜168時間程度が望ましい。
上記のようにして培養した後、培養物中から、目的物であるアラビノオリゴ糖生成酵素を採取及び精製するには、通常使用されている周知の手段、例えば濾過、遠心分離、イオン交換またはゲル濾過クロマトグラフィー、脱塩、膜濃縮、膜分離等の操作を必要に応じて適宜組み合わせて用いることができる。
一例を挙げれば、培養液から濾過、遠心分離等によって菌体を除去し、透析膜による脱塩操作を行なったものを酵素液として用いることができる。
ここで、酵素液は回収し、繰り返し使用することも可能である。
アラビノオリゴ糖の製造は、ビート搾汁粕やリンゴ搾汁粕などのアラビナン含有繊維分に、上記の方法で得られた酵素液を加えることにより糖化を行う。
反応温度は、酵素が失活しない範囲内、即ち20〜70℃、好ましくは40〜60℃の範囲がよい。
酵素反応pHは、酵素の至適条件下で反応を行うことが望ましく、pH3〜9、好ましくはpH4〜7の範囲とする。
反応時間は、使用するアラビナン含有繊維分の組成や形状と酵素添加量に依存するが、通常3〜72時間に設定するのが作業上好ましい。
反応が進むにつれ、アラビナン含有繊維分が加水分解され、アラビノオリゴ糖が生成、遊離するので、これを反応終了後、常法によって反応液中から分離する。
即ち、かかる場合に当該分野において通常使用されている周知の手段、例えば濾過、遠心分離、イオン交換または吸着クロマトグラフィー、膜濃縮、膜分離、溶媒抽出、減圧濃縮、結晶化等の操作を必要に応じて適宜組み合わせて用いることができる。
一例を挙げれば、反応液から濾過、遠心分離等によって繊維分等の残渣を除去し、次いでこの溶液を活性炭で処理して着色物質などを除き、更にイオン交換樹脂により脱イオンした後、濃縮してシロップあるいは粉末状にすることができる。
【0020】
本発明で使用するアラビノオリゴ糖は上記方法により製造されたものに限らず、アラビノオリゴ糖で有ればいずれでも使用でき、例えば酵素を用いずに化学的方法に得られたアラビノオリゴ糖も使用することができる。
【0021】
これらのアラビノオリゴ糖含有物を用いてのアポトーシス誘導の検定は、アラビノオリゴ糖含有物を添加した培養系でのガン細胞(HL60ヒト白血病細胞)の増殖性や、該細胞並びに該細胞核の形態変化、及び核DNAの断片化を観察することによって調べることが可能である。
アラビノオリゴ糖含有物を添加した培養系でのHL60ヒト白血病細胞の増殖性は、トリパンブルー色素排除能を示す生細胞数を白球計算盤を用いて測定することで、容易に検討できる。
アラビノオリゴ糖含有物の培養系での濃度が0.5mg/ml以上に調製された培養系では、HL60細胞の増殖性は明らかにアラビノオリゴ糖含有物を添加しない系に比較して劣ることが判明している。
このアラビノオリゴ糖含有物を含有する細胞系でのHL60細胞増殖性の低下は、次の試験例1に示すように、顕微鏡及びアガロースゲルによる電気泳動による核DNAの観察結果から、明らかにアポトーシスによる細胞死によるものであることが判明した。
【0022】
【実施例1】
【0023】
次に、本発明を実施例により詳しく説明するが、本発明はこれに限定されるものではない。
【0024】
a)酵素液の調製
ビート搾汁粕を粉末状に加工したビートファイバー(日本甜菜製糖製)20.0g、リン酸二水素カリウム3.0g、硫酸マグネシウム0.5g、コーンスティープリカー0.5gからなる培地1リットルを含むジャーファーメンター(サクラ精機製、培養槽容量1.5リットル)に、ペニシリウム・エスピーGALA22株(FERMP−18941)を培養したスラントへ滅菌水5mlと消泡剤を数滴入れ懸濁させものを無菌的に植菌し、温度30℃、pH5.0、通気量0.5L/min、回転数300rpmで72時間通気撹拌培養した。
培養終了後、遠心分離(5000G、10分)及び孔径0.45μmのフィルターにより菌体及び培地残渣を除去した。
続いて、分画分子量10000の限外濾過膜にて、20倍量まで濃縮した溶液を酵素液とした。
【0025】
b)アラビノオリゴ糖溶液の調製
粉砕処理したビート搾汁粕1.4kgを25mM酢酸緩衝液(pH5.0)35リットルに懸濁させた。
これを50℃まで加温した後、調製した酵素液1リットルを加え、同温度に保って24時間加水分解を行った。
その後、溶液温度を90℃に上げ、その温度を30分間保持し、酵素を失活させた。
これを遠心分離(5000G、5分)した後に、孔径0.45μmのフィルターで濾過することにより有用糖質を含む溶液を得た。
【0026】
c)アラビノオリゴ糖溶液の精製
この溶液を活性炭(カルゴン粒状活性炭)4kgを充填したカラム(直径12cm、長さ100cm)に添加した後、流速170ml/minで蒸留水100リットル及び5.0%エタノール50リットルで洗浄することで単糖類を除去した。
次に、10.0%エタノール50リットル、20.0%エタノール50リットル、30.0%エタノール50リットル、50.0%エタノール50リットルを順次流しアラビノオリゴ糖画分を得た。
これらを、エバポレーターで1リットルまで濃縮した後、陽イオン交換樹脂(DOWEX88)850gと陰イオン交換樹脂(ピュロライトA−10312)1500gを充填したカラム(直径6cm、長さ100cm)にアプライした。
流速150ml/minで80リットルの蒸留水を通液する事で、ガラクツロン酸の除去及び脱塩を行った。
【0027】
d)ガン細胞アポトーシス誘導剤の調製
ガラクツロン酸の除去及び脱塩を行った画分を、エバポレーターで200mlまで濃縮した後、凍結乾燥してガン細胞アポトーシス誘導剤としてのアラビノオリゴ糖組成物52.6gを得た。
上記のようにして得られたアラビノオリゴ糖組成物の平均重合度は2.8であった。
【0028】
【試験例1】
【0029】
次に、本発明区として上記実施例1で得た平均重合度2.8のアラビノオリゴ糖を成分とするガン細胞アポトーシス誘導剤を使用して、下記の方法によってガン細胞アポトーシス誘導試験を行った。
【0030】
ここで、HL60ヒト白血病細胞は、ヒューマンサイエンス研究資源バンクより分譲されたものを使用した。
該HL60細胞は、10%ウシ胎児血清を含むRPM11640培地(GIBCO)を用いて、37℃、5%CO存在下、相対湿度100%の条件で培養した。
HL60細胞を24穴プレートに1×10cells/mlになるように播種し、終濃度が5mg/mlとなるように本発明区のアラビノオリゴ糖の試料を培養液中に添加して24時間培養した後、トリパンブルー色素排除能を示す生細胞を、血球計算盤を用いてトリパンブルー色素排除能を示す生細胞数を計測した。
【0031】
対照試験として、アラビノオリゴ糖以外の糖質(アラビノース、ガラクツロン酸、グルコース、セロビオース、α−1,4キシロオリゴ糖、アラビナン)でも、本発明区と同様の条件及び手順で試験を行った。
【0032】
その結果を、各糖質におけるガン細胞の生存率を示すグラフとして、図1に示す。
該図1に示すように、本発明区のアラビノオリゴ糖は、添加24時間後のHL60細胞の生細胞数が約45%と、対照区の糖質と比べて最も強く抑制する。
【0033】
そこで、本発明区のアラビノオリゴ糖のHL60細胞増殖抑制効果を明らかにするため、各濃度のアラビノオリゴ糖の試料添加後、6〜48時間のHL60細胞の生細胞数を計測した。
その結果を、HL60生細胞数の測定結果を示すグラフとして、図2に示す。該図2に示すように、アラビノオリゴ糖は0.5mg/mlの濃度から明らかにHL60生細胞の増殖を抑制する。
【0034】
次に、HL60細胞の増殖抑制がアポトーシスに基づく細胞死であるかを検定するため、アポトーシスに特異的なDNAの断片化を観察した。
まず、細胞を20μlの溶解液[50mMTris−HCl(pH8.0)、100mMEDTA、0.5%SDS]に溶解し、1μlのRNaseA(10mg/ml溶解液)(SIGMA)を加えて、50℃で30分間インキュベートした。
その後、さらに1μlのProteinaseK(10mg/ml溶解液)(SIGMA)を加えて、50℃で60分間インキュベートした。
この細胞溶解液を、0.5μl/mlのethidiumbromide(和光純薬)を含んだ2%アガロースゲルで電気泳動し、UVイルミネーター上でDNAの断片化を観察した。
図3に、アガロース電気泳動の結果を示す写真を示す。
図3において、レーン左から、1番目はマーカー、2番目は無添加の対照区を示し、3〜6番目は本発明区のアラビノオリゴ糖添加区で、3番目はアラビノオリゴ糖0.5mg/ml添加区、4番目はアラビノオリゴ糖1.0mg/ml添加区、5番目はアラビノオリゴ糖5.0mg/ml添加区、6番目はアラビノオリゴ糖10.0mg/ml添加区を示す。
該図3に示すように、アラビノオリゴ糖は、0.5〜10mg/mlの濃度でHL60細胞に、アポトーシスに特徴的なヌクレオソーム単位でのDNAの断片化を誘導した。
【0035】
また、本発明区としてアラビノオリゴ糖5.0mg/ml添加区と、無添加の対照区とについて、HL60細胞の核DNAをヘキスト33258(和光純薬)で蛍光染色し、蛍光顕微鏡で観察した。
図4に、対照区の蛍光顕微鏡によるHL60細胞の観察結果を示す写真を示す。
また、図5に、発明区の蛍光顕微鏡によるHL60細胞の観察結果を示す写真を示す。
該図5に示すように、アラビノオリゴ糖添加により、アポトーシスに特徴的な核の凝縮及び断片化を観察した。
【0036】
【発明の効果】
【0037】
本発明のガン細胞アポトーシス誘導剤は、精製操作が容易であって、かつ収量が高く、安価で効率的に製造できる。
【図面の簡単な説明】
【図1】各糖質におけるガン細胞の生存率を示すグラフ
【図2】HL60生細胞数の測定結果を示すグラフ
【図3】アガロース電気泳動の結果を示す写真
【図4】対照区の蛍光顕微鏡によるHL60細胞の観察結果を示す写真
【図5】発明区の蛍光顕微鏡によるHL60細胞の観察結果を示す写真
[0001]
TECHNICAL FIELD OF THE INVENTION
[0002]
The present invention relates to a cancer cell apoptosis inducer, and more particularly, to a cancer cell apoptosis inducer containing an oligosaccharide-containing substance as a component.
[0003]
[Prior art]
[0004]
Conventionally, as a cancer cell apoptosis inducer containing an oligosaccharide-containing substance as a component, β-1,3 xylan obtained from a cell wall of a seaweed as described in Japanese Patent Application Laid-Open No. 2001-86999 (Patent Document 1). Is known, which comprises β-1,3 xylo-oligosaccharide as a main component, obtained by treating E. coli with β-1,3 xylanase.
The cancer cell apoptosis-inducing agent is prepared from scotch ivy, which is an algae of the family Crocodidae, by washing with deionized water, 1% hydrochloric acid solution and 23% sodium hydroxide solution, decolorizing with sodium chlorite solution, 10% sodium hydroxide By performing extraction with a solution and fractional purification by ethanol precipitation, β-1,3 xylan used as a raw material was obtained.
[0005]
[Patent Document 1]
JP 2001-86999 A
[Problems to be solved by the invention]
[0007]
However, the cancer cell-induced apoptosis inducer containing β-1,3 xylo-oligosaccharide as a main component is prepared from deionized water such as Srikkogita, which is an algae of the Ipaceae family, in order to obtain β-1,3 xylan used as a raw material. Washing with 1% hydrochloric acid solution and 23% sodium hydroxide solution, decolorization with sodium chlorite solution, extraction with 10% sodium hydroxide solution, fractional purification by ethanol precipitation, and multi-step treatment must be performed. Therefore, there is a problem in that the purification operation is very complicated and the yield is low, and it has been very difficult to produce inexpensively and efficiently.
[0008]
Therefore, the problem to be solved by the present invention is to induce cancer cell apoptosis containing oligosaccharide-containing components as components, which are easy to purify, have a high yield, and can be produced inexpensively and efficiently. To obtain an agent.
[0009]
[Means for Solving the Problems]
[0010]
Means for solving the problems of the present invention are as follows.
First, a cancer cell apoptosis inducer containing an arabino-oligosaccharide-containing component as a component.
Second, a cancer cell apoptosis-inducing agent comprising an arabino-oligosaccharide-containing substance having an average degree of polymerization of 10 or less.
Third, arabinonan-containing fiber is hydrolyzed using an arabino-oligosaccharide-forming enzyme derived from Penicillium sp. GALA22 deposited at the Patent Organism Depositary of the National Institute of Advanced Industrial Science and Technology as FERMP-188941. A cancer cell apoptosis inducer comprising the arabino-oligosaccharide-containing material obtained as a component.
Here, as the arabinan-containing fiber, besides beet juice lees, beet fiber, beet pulp, apple juice lees, apple fiber, peanut lees, citrus peel or pulp, okara, soy fiber More than one can be used.
Fourth, the cancer cell apoptosis-inducing agent according to the third above, wherein beet juice lees is used as the arabinan-containing fiber component.
[0011]
The arabino-oligosaccharide composition used in the present invention preferably has an average degree of polymerization of saccharide of 10 or less, and the binding mode is not particularly limited.
The average degree of polymerization is a value defined by the amount of total sugar (converted to arabinose) / the amount of reducing sugar (converted to arabinose). The total amount of sugar is determined by measuring the amount of reducing sugar by the phenol-sulfuric acid method and the amount of reducing sugar by the Nelson-Somogi method. Can be
[0012]
The arabino-oligosaccharide in the present invention is an oligosaccharide composed of 2 to 10 saccharides containing 1 to 10 molecules of arabinose. The bonding mode is not limited to a linear one composed of α-1,5 bonds, but also includes those having various branched structures including α-1,2 and α-1,3 bonds. This includes those in which at least one sugar other than arabinose, such as xylose, glucose, galactose, mannose and galacturonic acid, is bonded to the reducing end or non-reducing end, or in the molecule.
[0013]
The arabino-oligosaccharide-containing material used in the present invention may be any of powder, liquid, crystal and granules.
[0014]
BEST MODE FOR CARRYING OUT THE INVENTION
[0015]
The arabino-oligosaccharide-containing material used in the present invention is obtained by hydrolyzing beet juice cake or apple juice cake with an enzyme such as endoarabinase or arabinofuranosidase to obtain an oligosaccharide mixture. It can be obtained by separating and collecting arabino-oligosaccharide from the saccharide mixture.
In this case, any enzyme agent can be used.
When a commercially available enzyme is used, it is difficult to obtain a purified product. Therefore, a fibrinolytic enzyme may be used.
Examples thereof include Pectinase G Amano (trade name) manufactured by Amano Enzyme Co., Ltd., and Sumiteam AC (trade name) manufactured by Shin Nippon Chemical Industry Co., Ltd.
[0016]
In the hydrolysis treatment of beet juice lees and apple juice lees with an enzyme, a free enzyme or an enzyme immobilized on a carrier may be used.
In addition, the hydrolysis treatment with the enzyme may be performed by a continuous method or a batch method, and various conditions such as the type and origin of the enzyme, the amount of the enzyme added, the temperature at the time of treatment, pH, temperature, etc. It is good to select and process according to the situation.
[0017]
The oligosaccharide-containing saccharide mixture solution obtained as described above is separated by a conventional method.
That is, in such a case, well-known means usually used in the art, such as filtration, centrifugation, ion exchange or adsorption chromatography, membrane concentration, membrane separation, solvent extraction, concentration under reduced pressure, crystallization and the like become necessary. They are used in combination as appropriate.
For example, filtration, centrifugation or the like is used to remove residues such as fibers from the sugar mixture solution, and then the solution is treated with activated carbon to remove coloring substances and the like, and further desalted with an ion exchange resin, and then concentrated. Into a syrup or a powder.
[0018]
Further, by using arabino-oligosaccharide-forming enzyme produced by Penicillium sp. GALA22 deposited at National Institute of Advanced Industrial Science and Technology, Patent Organism Depositary as FERMP-18941, the arabinan-containing fiber is hydrolyzed. The method for producing the resulting arabino-oligosaccharide-containing material is described below.
[0019]
First, Penicillium sp. GALA22 is cultured to prepare an arabino-oligosaccharide-forming enzyme.
The culture of the strain is carried out under aerobic conditions using a liquid medium or a solid medium containing a carbon source, a nitrogen source, inorganic salts and the like.
As the carbon source, arabinan-containing fiber such as beet juice lees and apple juice lees is used.
These fibers may be used after being subjected to a pulverizing treatment or the like.
As the nitrogen source, nitrogen compounds usable by microorganisms, for example, yeast extract, peptone, malt extract, corn steep liquor and the like are used.
As the inorganic salts, for example, salts such as magnesium sulfate, sodium nitrate, potassium dihydrogen phosphate, and calcium hydroxide are used.
In addition to these carbon sources, nitrogen sources, and inorganic salts, various organic and inorganic substances necessary for the growth of filamentous fungi can be further added, if necessary.
As a method of culturing in the above-mentioned medium, either solid culturing or liquid culturing may be used, but shaking cultivation or aeration and stirring cultivation using a fermenter or the like is preferable.
The culture temperature is not particularly limited as long as it is within the range in which it can grow, but is preferably around 30 ° C.
The culture pH is not particularly limited as long as it can be grown, but is preferably around pH 3-5.
The culture time is not particularly limited, but is preferably about 24 to 168 hours.
After culturing as described above, the target arabino-oligosaccharide-forming enzyme can be collected and purified from the culture by well-known means commonly used, for example, filtration, centrifugation, ion exchange or gel filtration. Operations such as chromatography, desalting, membrane concentration, and membrane separation can be appropriately combined and used as necessary.
For example, a culture solution obtained by removing bacterial cells from a culture solution by filtration, centrifugation, or the like, and performing a desalting operation using a dialysis membrane can be used as the enzyme solution.
Here, the enzyme solution can be collected and used repeatedly.
In the production of arabino-oligosaccharide, saccharification is carried out by adding the enzyme solution obtained by the above method to arabinan-containing fiber such as beet juice cake and apple juice cake.
The reaction temperature is within a range where the enzyme is not inactivated, that is, 20 to 70 ° C, preferably 40 to 60 ° C.
It is desirable that the enzyme reaction is carried out under the optimum conditions for the enzyme, and the pH is in the range of pH 3 to 9, preferably pH 4 to 7.
The reaction time depends on the composition and shape of the arabinan-containing fiber used and the amount of enzyme added, but it is usually preferable to set the reaction time at 3 to 72 hours.
As the reaction proceeds, the arabinan-containing fiber component is hydrolyzed, and arabino-oligosaccharide is generated and released. After completion of the reaction, the arabino-oligosaccharide is separated from the reaction solution by a conventional method.
That is, in such a case, it is necessary to use well-known means commonly used in the art, such as filtration, centrifugation, ion exchange or adsorption chromatography, membrane concentration, membrane separation, solvent extraction, vacuum concentration, crystallization, and the like. They can be used in combination as appropriate.
For example, the reaction solution is filtered, centrifuged to remove residues such as fibers, and then the solution is treated with activated carbon to remove coloring substances and the like, further deionized with an ion exchange resin, and then concentrated. Syrup or powder.
[0020]
The arabino-oligosaccharide used in the present invention is not limited to those produced by the above method, and any arabino-oligosaccharide can be used as long as it is an arabino-oligosaccharide.For example, it is also possible to use arabino-oligosaccharide obtained by a chemical method without using an enzyme. it can.
[0021]
Assays for apoptosis induction using these arabino-oligosaccharide-containing substances include the proliferative properties of cancer cells (HL60 human leukemia cells) in culture systems to which arabino-oligosaccharide-containing substances have been added, and the morphological changes of the cells and the cell nuclei. It is possible to check by observing the fragmentation of nuclear DNA.
Proliferation of HL60 human leukemia cells in a culture system to which an arabino-oligosaccharide-containing substance has been added can be easily examined by measuring the number of viable cells exhibiting trypan blue dye exclusion ability using a leukocyte calculator.
In the culture system in which the concentration of the arabino-oligosaccharide-containing material in the culture system was adjusted to 0.5 mg / ml or more, it was found that the proliferation of HL60 cells was clearly inferior to the system without the addition of the arabino-oligosaccharide-containing material. ing.
The decrease in the HL60 cell proliferation in the cell line containing the arabino-oligosaccharide-containing material was clearly observed by the observation of nuclear DNA by electrophoresis with a microscope and agarose gel, as shown in the following Test Example 1. It turned out to be due to death.
[0022]
Embodiment 1
[0023]
Next, the present invention will be described in detail with reference to examples, but the present invention is not limited to these examples.
[0024]
a) Preparation of Enzyme Solution From beet fiber (manufactured by Nippon Sugar Beet Sugar Co., Ltd.) obtained by processing beet juice lees into powder, 20.0 g, potassium dihydrogen phosphate 3.0 g, magnesium sulfate 0.5 g, and corn steep liquor 0.5 g Into a jar fermenter (manufactured by Sakura Seiki Co., Ltd., culture tank capacity: 1.5 liters) containing 1 liter of medium, 5 ml of sterilized water and several drops of an antifoaming agent are added to a slant in which Penicillium sp. The suspension was aseptically inoculated, and cultured under aeration and stirring at a temperature of 30 ° C., a pH of 5.0, an aeration rate of 0.5 L / min, and a rotation speed of 300 rpm for 72 hours.
After completion of the culture, the cells and medium residues were removed by centrifugation (5000 G, 10 minutes) and a filter having a pore size of 0.45 μm.
Subsequently, a solution concentrated to a 20-fold amount with an ultrafiltration membrane having a molecular weight cut off of 10,000 was used as an enzyme solution.
[0025]
b) Preparation of arabino-oligosaccharide solution 1.4 kg of pulverized beet juice cake was suspended in 35 L of 25 mM acetate buffer (pH 5.0).
After heating this to 50 ° C., 1 liter of the prepared enzyme solution was added, and hydrolysis was carried out at the same temperature for 24 hours.
Thereafter, the temperature of the solution was raised to 90 ° C., and the temperature was maintained for 30 minutes to inactivate the enzyme.
After centrifugation (5000 G, 5 minutes), the solution was filtered with a filter having a pore size of 0.45 μm to obtain a solution containing a useful saccharide.
[0026]
c) Purification of arabino-oligosaccharide solution This solution was added to a column (diameter 12 cm, length 100 cm) packed with 4 kg of activated carbon (calgon granular activated carbon), and then 100 liters of distilled water and 50% ethanol 50% at a flow rate of 170 ml / min. Monosaccharides were removed by washing with liters.
Next, 50 liters of 10.0% ethanol, 50 liters of 20.0% ethanol, 50 liters of 30.0% ethanol, and 50 liters of 50.0% ethanol were sequentially passed to obtain an arabino-oligosaccharide fraction.
After concentrating these to 1 liter with an evaporator, they were applied to a column (diameter 6 cm, length 100 cm) packed with 850 g of cation exchange resin (DOWEX 88) and 1500 g of anion exchange resin (Purolite A-10312).
Galacturonic acid was removed and desalted by passing 80 liters of distilled water at a flow rate of 150 ml / min.
[0027]
d) Preparation of cancer cell apoptosis inducer The fraction from which galacturonic acid was removed and desalted was concentrated to 200 ml with an evaporator, and then lyophilized to obtain 52.6 g of an arabino-oligosaccharide composition as a cancer cell apoptosis inducer. Obtained.
The average polymerization degree of the arabino-oligosaccharide composition obtained as described above was 2.8.
[0028]
[Test Example 1]
[0029]
Next, a cancer cell apoptosis induction test was carried out by the following method using the cancer cell apoptosis-inducing agent containing arabino-oligosaccharide having an average degree of polymerization of 2.8 obtained in Example 1 as the present invention.
[0030]
Here, HL60 human leukemia cells used were purchased from the Human Science Research Resource Bank.
The HL60 cells were cultured in RPM11640 medium (GIBCO) containing 10% fetal bovine serum at 37 ° C. in the presence of 5% CO 2 at a relative humidity of 100%.
HL60 cells are seeded on a 24-well plate at 1 × 10 5 cells / ml, and a sample of arabino-oligosaccharide of the present invention is added to the culture solution to a final concentration of 5 mg / ml and cultured for 24 hours. After that, the number of viable cells exhibiting trypan blue dye exclusion ability was counted using a hemocytometer.
[0031]
As a control test, saccharides other than arabino-oligosaccharide (arabinose, galacturonic acid, glucose, cellobiose, α-1,4 xylo-oligosaccharide, arabinan) were also tested under the same conditions and procedures as in the present invention.
[0032]
The results are shown in FIG. 1 as a graph showing the survival rate of cancer cells in each carbohydrate.
As shown in FIG. 1, the arabino-oligosaccharide of the present invention group has the most viable cell number of HL60 cells 24 hours after addition, about 45%, as compared with the carbohydrate of the control group.
[0033]
Then, in order to clarify the inhibitory effect of the arabino-oligosaccharide of the present invention on the growth of HL60 cells, the number of viable HL60 cells was counted for 6 to 48 hours after the addition of the sample of each concentration of arabino-oligosaccharide.
The result is shown in FIG. 2 as a graph showing the measurement result of the number of viable HL60 cells. As shown in FIG. 2, arabino-oligosaccharide clearly inhibits the growth of living HL60 cells at a concentration of 0.5 mg / ml.
[0034]
Next, in order to examine whether the growth suppression of HL60 cells was cell death based on apoptosis, fragmentation of DNA specific to apoptosis was observed.
First, cells were lysed in 20 μl of a lysis solution [50 mM Tris-HCl (pH 8.0), 100 mM EDTA, 0.5% SDS], and 1 μl of RNaseA (10 mg / ml lysis solution) (SIGMA) was added. Incubated for 30 minutes.
Thereafter, 1 μl of Proteinase K (10 mg / ml solution) (SIGMA) was further added, and the mixture was incubated at 50 ° C. for 60 minutes.
The cell lysate was electrophoresed on a 2% agarose gel containing 0.5 μl / ml of ethidium bromide (Wako Pure Chemical Industries), and DNA fragmentation was observed on a UV illuminator.
FIG. 3 shows a photograph showing the results of agarose electrophoresis.
In FIG. 3, from the lane left, the first is a marker, the second is a control group without addition, the third to sixth are arabino-oligosaccharide-added groups of the present invention, and the third is arabino-oligosaccharide 0.5 mg / ml added. The fourth, the arabino-oligosaccharide 1.0 mg / ml addition section, the fifth, the arabino-oligosaccharide 5.0 mg / ml addition section, and the sixth, the arabino-oligosaccharide 10.0 mg / ml addition section.
As shown in FIG. 3, arabino-oligosaccharides induced DNA fragmentation in nucleosome units characteristic of apoptosis in HL60 cells at a concentration of 0.5 to 10 mg / ml.
[0035]
In addition, in the group of the present invention in which 5.0 mg / ml of arabino-oligosaccharide was added and in the control group where no arabino-oligosaccharide was added, nuclear DNA of HL60 cells was fluorescently stained with Hoechst 33258 (Wako Pure Chemical Industries) and observed with a fluorescence microscope.
FIG. 4 shows a photograph showing the results of observation of HL60 cells by a fluorescence microscope in the control section.
FIG. 5 shows a photograph showing the results of observation of HL60 cells by a fluorescence microscope in the invention section.
As shown in FIG. 5, nuclear addition and fragmentation characteristic of apoptosis were observed by the addition of arabino-oligosaccharide.
[0036]
【The invention's effect】
[0037]
The cancer cell apoptosis-inducing agent of the present invention is easy to purify, has a high yield, can be inexpensively and efficiently produced.
[Brief description of the drawings]
FIG. 1 is a graph showing the survival rate of cancer cells in each carbohydrate. FIG. 2 is a graph showing the results of measuring the number of viable HL60 cells. FIG. 3 is a photograph showing the results of agarose electrophoresis. FIG. FIG. 5 is a photograph showing a result of observation of HL60 cells by a microscope. FIG. 5 is a photograph showing a result of observation of HL60 cells by a fluorescence microscope in an invention section.

Claims (4)

アラビノオリゴ糖含有物を成分とする、ガン細胞アポトーシス誘導剤。An agent for inducing apoptosis of cancer cells, comprising an arabino-oligosaccharide-containing component. 平均重合度が10以下のアラビノオリゴ糖含有物を成分とする、ガン細胞アポトーシス誘導剤。An agent for inducing apoptosis of cancer cells, comprising an arabino-oligosaccharide-containing substance having an average degree of polymerization of 10 or less. FERMP−18941として寄託されているペニシリウム・エスピーGALA22によるアラビノオリゴ糖生成酵素を用い、アラビナン含有繊維分を加水分解することで得られたアラビノオリゴ糖含有物を成分とする、ガン細胞アポトーシス誘導剤。A cancer cell apoptosis-inducing agent comprising, as a component, an arabino-oligosaccharide-containing substance obtained by hydrolyzing an arabinan-containing fiber using an arabino-oligosaccharide-forming enzyme deposited with Penicillium sp. GALA22 deposited as FERMP-18941. 前記アラビナン含有繊維分として、ビート搾汁粕を用いる、請求項3に記載のガン細胞アポトーシス誘導剤。The cancer cell apoptosis-inducing agent according to claim 3, wherein beet juice lees is used as the arabinan-containing fiber component.
JP2002349884A 2002-12-02 2002-12-02 Cancer cell apoptosis inducer Expired - Fee Related JP3899462B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2002349884A JP3899462B2 (en) 2002-12-02 2002-12-02 Cancer cell apoptosis inducer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2002349884A JP3899462B2 (en) 2002-12-02 2002-12-02 Cancer cell apoptosis inducer

Publications (2)

Publication Number Publication Date
JP2004182628A true JP2004182628A (en) 2004-07-02
JP3899462B2 JP3899462B2 (en) 2007-03-28

Family

ID=32752291

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002349884A Expired - Fee Related JP3899462B2 (en) 2002-12-02 2002-12-02 Cancer cell apoptosis inducer

Country Status (1)

Country Link
JP (1) JP3899462B2 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012187099A (en) * 2011-02-21 2012-10-04 Shinshu Univ Ferulic acid bonding type saccharide and production method therefor
JP2018517677A (en) * 2015-04-23 2018-07-05 カレイド・バイオサイエンシズ・インコーポレイテッド Glycan therapeutic agent and method
US11584805B2 (en) 2014-07-09 2023-02-21 Dsm Nutritional Products, Llc Oligosaccharide compositions and methods for producing thereof
US11653676B2 (en) 2015-01-26 2023-05-23 Dsm Nutritional Products, Llc Oligosaccharide compositions for use as animal feed and methods of producing thereof

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012187099A (en) * 2011-02-21 2012-10-04 Shinshu Univ Ferulic acid bonding type saccharide and production method therefor
US11584805B2 (en) 2014-07-09 2023-02-21 Dsm Nutritional Products, Llc Oligosaccharide compositions and methods for producing thereof
US11653676B2 (en) 2015-01-26 2023-05-23 Dsm Nutritional Products, Llc Oligosaccharide compositions for use as animal feed and methods of producing thereof
JP2018517677A (en) * 2015-04-23 2018-07-05 カレイド・バイオサイエンシズ・インコーポレイテッド Glycan therapeutic agent and method
JP2021001208A (en) * 2015-04-23 2021-01-07 カレイド・バイオサイエンシズ・インコーポレイテッド Glycan therapeutics and related methods thereof
US10894057B2 (en) 2015-04-23 2021-01-19 Kaleido Biosciences, Inc. Glycan therapeutic compositions and related methods thereof
US11883422B2 (en) 2015-04-23 2024-01-30 Dsm Nutritional Products, Llc Glycan therapeutic compositions and related methods thereof

Also Published As

Publication number Publication date
JP3899462B2 (en) 2007-03-28

Similar Documents

Publication Publication Date Title
CN111440885B (en) Molecular marker for identifying sanzan glue and synthetic bacteria thereof, and preparation and application thereof
JP2010233576A (en) Process for purifying difructose dianhydride iii crystal
CN109182486B (en) Primer of molecular marker for identifying sanzan gum, gellan gum and welan gum, molecular marker and application
JP5467297B2 (en) Biosurfactant manufacturing method
Iwasaki et al. Purification of pectate oligosaccharides showing root-growth-promoting activity in lettuce using ultrafiltration and nanofiltration membranes
CN112515032A (en) Extraction method of selenoprotein in cardamine violifolia, selenoprotein obtained by extraction method and application of selenoprotein
JP3899462B2 (en) Cancer cell apoptosis inducer
CN115287275B (en) Method for purifying hyaluronidase
CN105624067B (en) Marine bacterium Pseudomonas sp SC127 and ulva sulfate rhamnosidase prepared by same
JP4391114B2 (en) Enzyme mass production
CN112358985B (en) Pradazobium and application thereof in preparation of water-soluble beta-1, 3 glucan
JPH03505815A (en) Large-scale purification method for high-purity heparinase
JP2002065292A (en) Method for manufacturing polysaccharide
CN103602652A (en) Purification method for food-grade neutral protease
Zhang et al. Hydrophobicity and iron coagulation of extracellular polymeric substance from colonial Microcystis
KR100253423B1 (en) Process for purifying erythritol
KR100312638B1 (en) Method for manufacturing high purity hyaluronic acid
JP3840538B2 (en) Method for producing D-tagatose
JP2001086999A (en) Composition containing xylooligosaccharide and carcinoma cell apoptosis inducer
RU2230119C1 (en) Method for preparing disaccharide
JP3774430B2 (en) Method for producing oligosaccharide-containing material by Penicillium sp
CN114560962A (en) Preparation method of marine oligosaccharide with anti-tumor activity, marine oligosaccharide and application thereof
JP3594650B2 (en) Dextran production method
Bhagwat et al. Differential gene action in Neurospora crassa
SU1011685A1 (en) Process for producing mannane

Legal Events

Date Code Title Description
A711 Notification of change in applicant

Effective date: 20060920

Free format text: JAPANESE INTERMEDIATE CODE: A712

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20061114

A61 First payment of annual fees (during grant procedure)

Effective date: 20061213

Free format text: JAPANESE INTERMEDIATE CODE: A61

A61 First payment of annual fees (during grant procedure)

Effective date: 20061222

Free format text: JAPANESE INTERMEDIATE CODE: A61

R150 Certificate of patent (=grant) or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (prs date is renewal date of database)

Year of fee payment: 4

Free format text: PAYMENT UNTIL: 20110112

FPAY Renewal fee payment (prs date is renewal date of database)

Year of fee payment: 4

Free format text: PAYMENT UNTIL: 20110112

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120112

Year of fee payment: 5

FPAY Renewal fee payment (prs date is renewal date of database)

Year of fee payment: 5

Free format text: PAYMENT UNTIL: 20120112

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130112

Year of fee payment: 6

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140112

Year of fee payment: 7

LAPS Cancellation because of no payment of annual fees